Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

CHOP chemotherapy causes many side effects but is generally well tolerated.

Scalp cooling effectively reduces hair loss from chemotherapy.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Chemotherapy improved a girl's painful foot condition linked to pachyonychia congenita.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Some cancer treatments can cause abnormal fine hair growth.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Povidone-iodine nail solution effectively treats nail infections caused by chemotherapy.

Some breast cancer chemotherapy can cause permanent hair loss.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

The treatments for fungal nail infection, hair loss in men, benign nail tumor, and chemotherapy-associated nail bed inflammation are effective and safe.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Alopecia mucinosa on the face can be linked to mycosis fungoides, a type of lymphoma.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.